Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 53 is a noncoding, nonfunctional genomic segment classified as a pseudogene homologous to the 5S ribosomal RNA gene[2]. Unlike canonical 5S rRNA genes, which encode 5S rRNA—a ~120-nucleotide component of the large ribosomal subunit integral for ribosome structure and function[1][3][5]—RNA5SP53 does not contribute to ribosome biogenesis or protein synthesis. Pseudogenes are typically genomic remnants of once-functional genes, generated by duplication or retrotransposition events, and generally lack active transcription, regulatory roles, or protein products. This locus has no known implication in disease, drug interactions, or biomarker usage. Context: - Functional 5S rRNA is an essential part of the ribosome, but pseudogenes like RNA5SP53 are essentially molecular fossils without active roles. - Molecular databases (Biogps, NCBI gene reports) consistently describe RNA5SP53 as a pseudogene, not involved in therapeutic targeting[2]. - No literature supports roles in signaling, metabolism, transport, or disease. Additional notes: - This gene is not to be confused with the functional 5S rRNA genes, which play key structural and catalytic roles in translation[1][5]. - There are many similar pseudogenes (like RNA5SP203) categorized in genome databases, all considered nonfunctional[4]. In summary, RNA, 5S ribosomal pseudogene 53 (RNA5SP53) is a human pseudogene and not a drug target, functional receptor, enzyme, or molecule with clinical relevance. Its main identifiers are used for genomic annotation, and it has no known biological, pathological, or therapeutic role[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 53 (RNA5SP53).